Case Report: Controversies in managing pulmonary enteric adenocarcinoma: reflections from an early-stage case

Pulmonary enteric adenocarcinoma (PEAC) is a rare non-small cell lung cancer subtype characterized by predominant intestinal differentiation (≥50%) and histological resemblance to colorectal adenocarcinoma. We report a 70-year-old male ex-smoker with an incidentally detected 18×11 mm spiculated lung...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuchen Bao, Dongdong Liu, Yanzhe Wang, Zhigang Wu, Haitao Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1603084/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689672845885440
author Yuchen Bao
Dongdong Liu
Yanzhe Wang
Zhigang Wu
Haitao Wang
author_facet Yuchen Bao
Dongdong Liu
Yanzhe Wang
Zhigang Wu
Haitao Wang
author_sort Yuchen Bao
collection DOAJ
description Pulmonary enteric adenocarcinoma (PEAC) is a rare non-small cell lung cancer subtype characterized by predominant intestinal differentiation (≥50%) and histological resemblance to colorectal adenocarcinoma. We report a 70-year-old male ex-smoker with an incidentally detected 18×11 mm spiculated lung nodule on chest CT, which subsequently demonstrated intense FDG uptake (SUVmax 14.0) on PET-CT. Histopathological evaluation confirmed PEAC. Immunohistochemistry revealed HER2 overexpression (3+) and intestinal differentiation markers (CK7+, CK20+, CDX2+, Villin+), while molecular testing showed wild-type ERBB2 and no actionable mutations. The patient underwent successful R0 resection with no recurrence at 8-month follow-up. This case underscores the critical importance of a multimodal diagnostic approach integrating immunohistochemical markers (notably CK7’s superior specificity), PET-CT imaging, and endoscopic evaluation to reliably differentiate PEAC from metastatic gastrointestinal malignancies. Furthermore, the patient’s favorable outcome following R0 resection without adjuvant therapy reinforces surgical intervention as the cornerstone of treatment for localized PEAC, particularly in early-stage disease. Advanced cases require early multidisciplinary collaboration to develop individualized treatment.
format Article
id doaj-art-690605ae2a654792ad94b5fe53e4674d
institution DOAJ
issn 2234-943X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-690605ae2a654792ad94b5fe53e4674d2025-08-20T03:21:32ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-06-011510.3389/fonc.2025.16030841603084Case Report: Controversies in managing pulmonary enteric adenocarcinoma: reflections from an early-stage caseYuchen Bao0Dongdong Liu1Yanzhe Wang2Zhigang Wu3Haitao Wang4Hangzhou Normal University, Hangzhou, Zhejiang, ChinaCancer Center, Department of Thoracic Surgery, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, ChinaZhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaCancer Center, Department of Thoracic Surgery, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, ChinaCancer Center, Department of Thoracic Surgery, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, ChinaPulmonary enteric adenocarcinoma (PEAC) is a rare non-small cell lung cancer subtype characterized by predominant intestinal differentiation (≥50%) and histological resemblance to colorectal adenocarcinoma. We report a 70-year-old male ex-smoker with an incidentally detected 18×11 mm spiculated lung nodule on chest CT, which subsequently demonstrated intense FDG uptake (SUVmax 14.0) on PET-CT. Histopathological evaluation confirmed PEAC. Immunohistochemistry revealed HER2 overexpression (3+) and intestinal differentiation markers (CK7+, CK20+, CDX2+, Villin+), while molecular testing showed wild-type ERBB2 and no actionable mutations. The patient underwent successful R0 resection with no recurrence at 8-month follow-up. This case underscores the critical importance of a multimodal diagnostic approach integrating immunohistochemical markers (notably CK7’s superior specificity), PET-CT imaging, and endoscopic evaluation to reliably differentiate PEAC from metastatic gastrointestinal malignancies. Furthermore, the patient’s favorable outcome following R0 resection without adjuvant therapy reinforces surgical intervention as the cornerstone of treatment for localized PEAC, particularly in early-stage disease. Advanced cases require early multidisciplinary collaboration to develop individualized treatment.https://www.frontiersin.org/articles/10.3389/fonc.2025.1603084/fullpulmonary enteric adenocarcinoma (PEAC)PET-CTmultidisciplinary diagnosissurgical resectioncase report
spellingShingle Yuchen Bao
Dongdong Liu
Yanzhe Wang
Zhigang Wu
Haitao Wang
Case Report: Controversies in managing pulmonary enteric adenocarcinoma: reflections from an early-stage case
Frontiers in Oncology
pulmonary enteric adenocarcinoma (PEAC)
PET-CT
multidisciplinary diagnosis
surgical resection
case report
title Case Report: Controversies in managing pulmonary enteric adenocarcinoma: reflections from an early-stage case
title_full Case Report: Controversies in managing pulmonary enteric adenocarcinoma: reflections from an early-stage case
title_fullStr Case Report: Controversies in managing pulmonary enteric adenocarcinoma: reflections from an early-stage case
title_full_unstemmed Case Report: Controversies in managing pulmonary enteric adenocarcinoma: reflections from an early-stage case
title_short Case Report: Controversies in managing pulmonary enteric adenocarcinoma: reflections from an early-stage case
title_sort case report controversies in managing pulmonary enteric adenocarcinoma reflections from an early stage case
topic pulmonary enteric adenocarcinoma (PEAC)
PET-CT
multidisciplinary diagnosis
surgical resection
case report
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1603084/full
work_keys_str_mv AT yuchenbao casereportcontroversiesinmanagingpulmonaryentericadenocarcinomareflectionsfromanearlystagecase
AT dongdongliu casereportcontroversiesinmanagingpulmonaryentericadenocarcinomareflectionsfromanearlystagecase
AT yanzhewang casereportcontroversiesinmanagingpulmonaryentericadenocarcinomareflectionsfromanearlystagecase
AT zhigangwu casereportcontroversiesinmanagingpulmonaryentericadenocarcinomareflectionsfromanearlystagecase
AT haitaowang casereportcontroversiesinmanagingpulmonaryentericadenocarcinomareflectionsfromanearlystagecase